Related Experiment Video
Updated: Jul 4, 2025

10:26
RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
Published on: March 11, 2014
27.4K
SYT7 (synaptotagmin 7) promotes cervical squamous cell carcinoma
Jinbing Huang1, Wensheng Xu1, Qiaoqiao Huang1
1Department of Gynecology and Obstetrics, The First Affiliated Hospital of Guangxi Medical University, 6 Shuangyong Road, Nanning, Guangxi, China.
Heliyon
|February 5, 2024
Summary
Synaptotagmin 7 (SYT7) promotes cervical squamous cell carcinoma (CESC) growth. Silencing SYT7 inhibited tumor cell proliferation, migration, and invasion, offering a potential therapeutic target for CESC.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Cervical squamous cell carcinoma (CESC) is a major cause of cancer mortality worldwide.
- The specific role of synaptotagmin 7 (SYT7) in CESC pathogenesis is not well understood.
Purpose of the Study:
- To investigate the expression and function of SYT7 in CESC.
- To determine the potential of SYT7 as a therapeutic target for CESC.
Main Methods:
- Immunohistochemistry was used to assess SYT7 expression in CESC tissues.
- SYT7 knockdown cell line models (HeLa, SiHa) were created using lentiviral shRNA.
- In vitro functional assays (proliferation, colony formation, apoptosis, migration, invasion) and in vivo xenograft models were employed.
Main Results:
- SYT7 expression was significantly elevated in CESC tissues compared to normal tissues.
- SYT7 knockdown suppressed cell proliferation, colony formation, migration, and invasion, while enhancing apoptosis.
- In vivo, SYT7 knockdown inhibited tumor growth and tumorigenic potential.
- SYT7 depletion altered the expression of key apoptosis and signaling pathway genes.
Conclusions:
- SYT7 plays a tumor-promoting role in CESC.
- Targeting SYT7 may represent a novel therapeutic strategy for cervical squamous cell carcinoma.
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
5.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.1K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K

